Polydatin attenuates atherosclerosis in apolipoprotein E-deficient mice: Role of reverse cholesterol transport

Bryk, 2017, The role of oxidative stress and NADPH oxidase in the pathogenesis of atherosclerosis, Postepy. Hig. Med. Dosw., 71, 57, 10.5604/17322693.1229823 Chen, 2018, 2,3,4′,5-tetrahydroxystilbene-2-O-β-d-glycoside attenuates atherosclerosis in apolipoprotein E-deficient mice: role of reverse cholesterol transport, Can. J. Physiol. Pharmacol., 96, 8, 10.1139/cjpp-2017-0474 Cherkaoui-Malki, 2012, Hepatic steatosis and peroxisomal fatty acid beta-oxidation, Curr. Drug. Metab., 13, 1412, 10.2174/138920012803762765 Chistiakov, 2016, Macrophage-mediated cholesterol handling in atherosclerosis, J. Cell. Mol. Med., 20, 17, 10.1111/jcmm.12689 Dong, 2017, Xinxuekang regulates reverse cholesterol transport by improving high-density lipoprotein synthesis, maturation, and catabolism, J. Cardiovasc. Pharmacol., 70, 110, 10.1097/FJC.0000000000000500 Du, 2009, Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters, Phytomedicin, 16, 652, 10.1016/j.phymed.2008.10.001 Du, 2013, Polydatin: a review of pharmacology and pharmacokinetics, Pharm. Biol., 51, 1347, 10.3109/13880209.2013.792849 Guo, 2018, Cholesterol homeostasis and liver X receptor (LXR) in atherosclerosis, Cardiovasce. Hematol. Disord. Drug. Targets., 18, 27, 10.2174/1871529X18666180302113713 Hellerstein, 2014, Reverse cholesterol transport fluxes, Curr. Opin. Lipidol., 25, 40, 10.1097/MOL.0000000000000050 Huang, 2018, Polydatin attenuates atherosclerosis in ApoE −∕− mice through PBEF mediated reduction of cholesterol deposition, Am. J. Chin. Med., 11, 1 Jawien, 2012, The role of an experimental model of atherosclerosis: apoE-knockout mice in developing newdrugs against atherogenesis, Curr. Pharm. Biotechnol., 13, 2435, 10.2174/1389201011208062435 Li, 2017, Isofraxidin, a coumarin component improves high-fat diet induced hepatic lipid homeostasisdisorder and macrophage inflammation in mice, Food. Funct., 8, 2886, 10.1039/C7FO00290D Lin, 2015, Chicory, a typical vegetable in Mediterranean diet, exerts a therapeutic role in establishedatherosclerosis in apolipoprotein E-deficient mice, Mol. Nutr. Food. Res., 59, 1803, 10.1002/mnfr.201400925 Linton, 2017, SR-BI: a multifunctional receptor in cholesterol homeostasis and atherosclerosis, Trends. Endocrinol. Metab., 28, 461, 10.1016/j.tem.2017.02.001 Liu, 2017, Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice, Atherosclerosis, 262, 39, 10.1016/j.atherosclerosis.2017.05.003 Lu, 2008, ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation, Arterioscler. Thromb. Vasc. Biol., 28, 1820, 10.1161/ATVBAHA.108.169482 Ma, 2014, Cholesterol efflux is LXRα isoform-dependent in human macrophages, BMC. Cardiovasc. Disord., 14, 80, 10.1186/1471-2261-14-80 Mei, 2015, Lipid-free apolipoprotein A-I structure: insights into HDL formation and atherosclerosis development, Arch. Med. Res., 46, 351, 10.1016/j.arcmed.2015.05.012 Pandak, 2001, Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis, Am. J. Physiol. Gastrointest. Liver. Physiol., 281, G878, 10.1152/ajpgi.2001.281.4.G878 Tang, 2018, Salusin-α attenuates hepatic steatosis and atherosclerosis in high fat diet-fed low densitylipoprotein receptor deficient mice, Eur. J. Pharmacol., 830, 76, 10.1016/j.ejphar.2018.04.026 Strable, 2010, Genetic control of de novo lipogenesis: role in diet-induced obesity, Crit. Rev. Biochem. Mol. Biol., 45, 199, 10.3109/10409231003667500 Xing, 2009, Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits, Biomed. Pharmacother., 63, 457, 10.1016/j.biopha.2008.06.035 Xu, 2015, Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis, Lipids. Health. Dis., 14, 158, 10.1186/s12944-015-0141-z Yu, 2014, ABCG5/ABCG8 in cholesterol excretion and atherosclerosis, Clin. Chim. Acta., 428, 82, 10.1016/j.cca.2013.11.010 Zeng, 2018, Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependentcholesterol efflux in macrophages, Biomed. Pharmacother., 101, 543, 10.1016/j.biopha.2018.02.124 Zhang, 2012, Polydatin alleviates non-alcoholic fatty liver disease in rats by inhibiting the expression of TNF-α and SREBP-1c, Mol. Med. Rep., 6, 815, 10.3892/mmr.2012.1015